TradingMenu expanded
Forge Markets Forge Pro Browse Companies
DataMenu expanded
Forge Data Private Market Index Forge Accuidity Index IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Glossary Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Updates Forge Investment Outlook Startup News Tech IPO Calendar for 2024
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Forge Pro
Browse Companies
Data Menu expandedData
Forge Data
Private Market Index
Forge Accuidity Index
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Glossary
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Updates
Forge Investment Outlook
Startup News
Tech IPO Calendar for 2024
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Private Companies / Relievant Medsystems Stock

Relievant Medsystems Stock

www.relievant.comHealthcare / Medical DevicesFounded: 2006Funding to Date: $247.66MM

Relievant Medsystems developed a minimally-invasive outpatient procedure aimed at relieving chronic lower back pain. Their procedure, Intracept, focuses on vertebrogenic pain. Relievant Medsystems was founded in 2006 by Rex Peters, Samit Patel, and James Peacock and is headquartered in Minneapolis, MN.

Learn more about Relievant Medsystems IPO

Register To Buy and Sell Shares

For more details on financing and valuation for Relievant Medsystems, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Relievant Medsystems’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Relievant Medsystems.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Relievant Medsystems investors also invested in these private companies

New Enterprise Associates
ONSET Ventures
Morgenthaler Ventures
Canaan Partners
Endeavor Vision
Lightstone Ventures

Team

Management Team

Tyler Binney
Chief Executive Officer, President & Board Member
Christopher Geyen
Chief Financial Officer
Rex Peters
Co-Founder & Chief Operating Officer
Ray Baker MD
Chief Medical Officer

Board Members

Alexander Schmitz
Endeavour Vision
Arthur Taylor
Vensana Capital
Brenton Ahrens
Canaan Partners
Ross Jaffe MD
New Enterprise Associates
Jason Lettmann
Morgenthaler Ventures

Other companies like Relievant Medsystems in the Medical Devices sector

Neuralink

Sector
Healthcare / Medical Devices
Last Round Est. Valuation
$3.45B

Synchron

Sector
Healthcare / Medical Devices
Last Round Est. Valuation
$400.53MM

HistoSonics

Sector
Healthcare / Medical Devices
 
 

Levels

Sector
Healthcare / Medical Devices
Last Round Est. Valuation
$310.36MM

Eko Health

Sector
Healthcare / Medical Devices
Last Round Est. Valuation
$268.75MM

Beta Bionics

Sector
Healthcare / Medical Devices
Last Round Est. Valuation
$263MM

Imperative Care

Sector
Healthcare / Medical Devices
Last Round Est. Valuation
$1.35B

CMR Surgical

Sector
Healthcare / Medical Devices
 
 

AliveCor

Sector
Healthcare / Medical Devices
Last Round Est. Valuation
$943.68MM
Featured
Featured
December 21, 2023

Startup News: Acquired companies, a look back for 2023

Read More

News Highlights

Reuters 09/19/2023
Boston Scientific to buy chronic back pain therapy maker Relievant
Medical devices maker Boston Scientific (BSX.N) said on Tuesday it would buy private medical tech company Relievant Medsystems for an upfront cash payment of $850 million, gaining access to an FDA-cleared therapy for chronic pain. The Massachusetts-based company is also obliged to pay Relievant additional undisclosed payments based on sales performance over the next three years.
Globe Newswire 02/22/2023
Relievant Medsystems Announces Formal Coverage Recommendation from NASS for Basivertebral Nerve Ablation as a Treatment for Chronic Vertebrogenic Low Back Pain
Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic pain, a type of chronic low back pain (CLBP), today announced that the North American Spine Society (NASS) issued a formal coverage recommendation supportive of basivertebral nerve (BVN) ablation for the treatment of chronic vertebrogenic low back pain.

Trending Companies

Frequently Asked Questions

Updated on: Apr 20, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.